Revolution Growth first backed Tempus AI in 2017, with deep conviction in Eric Lefkofsky and his vision for the future of healthcare. Today, the company is trading on the Nasdaq. Bloomberg shares more on Tempus’s journey to IPO: https://lnkd.in/eepdtsH4
Revolution’s Post
More Relevant Posts
-
There's only one week until Inpart's exclusive webinar with DealForma CEO Chris Dokomajilar. Join us to review the 2023 year in life science partnering - the trends, the ups and downs, the rebounding M&A market, and are there hints of an IPO reboot, too? Reserve your seat today and don't miss out on all the data about all the deals, including those dropping this week at JPM. https://lnkd.in/ggvjA9qy #biopharmapartnering #openinnovation
To view or add a comment, sign in
-
The IPO market continues to show signs of life, and Tempus AI is the latest to file an S-1! 🚀 Tegus has you covered with: 🔍~100 transcripts covering Tempus, including 12 published within the past 2 months 📜 Direct access to the S-1 filing 📊 Tempus’ fully-drivable financial model From expert call transcripts to detailed financial models, you get everything you need to make smart decisions on a single platform from Tegus. Reach out to learn more. #IPO #Tempus #TEM #NASDAQ
To view or add a comment, sign in
-
PNBN Trending News: 2023 in Review: Region’s first life sciences IPO since 2021 tops industry’s biggest raises of the year https://lnkd.in/gerYc6N8 Despite economic headwinds, this year saw the region’s first life sciences IPO since 2021. Click here to view original post Click here to view Pennsylvania NY/NJ Biotech Networks Trending News
To view or add a comment, sign in
-
The Paramatrix Technologies IPO has wrapped up, and investors are now waiting to see if they’ve received any shares. - New Post: “Paramatrix Technologies IPO: How to Check Allotment Status” https://buff.ly/4dKfO3r #marketnewsviews #investmentopportunities #ipoallotmentguide #ipostatus #nse #paramatrixtechnologies #sme
To view or add a comment, sign in
-
Co-founder of Investica, an AI-powered equities research & discovery platform and Investing Education Academy. Ex Booz Allen Hamilton (HRSA.gov) & Accenture (USPS.com).
IPO ALERT! Astera Labs (ALAB) came public today. The company priced its #IPO at $36. Once the shares opened they immediately spiked 50% above their $36 listing price. The company makes specialized connectivity solutions for AI data centers. This is the first major AI-related IPO of the year so this will give us insights into if investor #AI appetite is ongoing or if AI fatigue is setting in. By the massive 50% jump in the shares, so far, investors AI appetite seems to be intact. But time will tell. #Stocks #stockmarket #stock #Nvidia
To view or add a comment, sign in
-
Are you ready for the summer? ‘Next wave of IPOs’ will arrive in summer, predicts biotech-focused VC partner Medicxi's Francesco De Rubertis (second from right) spoke to Fierce Biotech after participating in a panel at the LSX World Conference on how biotechs can prepare for an IPO. (James Waldron) Delegates at the LSX World Conference in London this week seemed to agree on one thing—the biotech IPO window finally re-opened this year. https://lnkd.in/e-zp2tkQ #ipo #listings #securities #srfc
To view or add a comment, sign in
-
At Nasdaq right now for the Sofinnova Investments & KKH Advisors Life Sciences Summit. The event kicked off with a great first panel “Current Biotech IPO Landscape Update”, moderated by Kimberly Ha, CEO, KKH Advisors with panelists, Jordan Saxe (Nasdaq), Paul Scansaroli, (Piper Sandler), Joshua Thomas (Altium Capital) and Chirag Surti (Morgan Stanley). Summarizing some really good advice for companies considering an #IPO: - A strong crossover round with enthusiastic investors sets an important base for a successful IPO: important for existing investors to fully cover base deal size at time of IPO launch. - Being a public company is a 2nd job, important to sufficiently prepare and start acting/thinking like a public company well in advance of IPO. - Validating partnerships and licensing agreements help prove attractiveness for future M&A perspective. Important to continue these strategic discussions in parallel to IPO prep.
To view or add a comment, sign in
-
Is the liquidation phase of Alpha Tau Medical shares (DRTS-$2) approaching an end? Below, courtesy of StockCharts dot com, is a point and figure image of the shares. 18 months ago, I thought the stock could be worth $400 a share. I noted that significant numbers of shares were in hands of investors in the predecessor company (Althera) and investors in Alpha Tau’s Special Purpose Acquisition Company. As the Althera investors are now in their eighties and nineties, chances seem good those shares have been dribbling into the market. Anyone who bought into the SPAC (@ $10) has a tax loss. Here’s my take from July, 2023. I now think a target of $400 a share is low. https://lnkd.in/gHqRsbGD
To view or add a comment, sign in
-
Kronox Lab Sciences Ltd. IPO Subscription Details! Keep a track of all the latest IPOs, including upcoming IPOs, ongoing IPOs, and IPO performance with Strike! #IPO #KronoxLabSciences #IPOAlert #StockMarket #FinancialNews #StrikeApp #IPOUpdates #MarketWatch #IPOTracker
To view or add a comment, sign in
-
Senior Solution Sales Executive, Capital Markets | Helping companies and law firms transform their Capital Markets transactions by leveraging technology to save time and improve processes
💨 Momentum for US #ipos is picking up 🏃♂️ According to Goldman Sachs, the best is yet to come for the new issues market. 😍 With Workiva, issuers & advisors can work together during #IPO drafting sessions within the platform - you always have access to the latest version of the document, without waiting for files to come back from a printer. 💥 👀 See how Weave knew Workiva had the right solution for working through their IPO. 👉 https://lnkd.in/eUC8amJ4 #capitalmarkets #customertestimonial #digitaltransformation #workiva https://lnkd.in/eP3wPDZe
IPOs Broaden in Busy Week With Goldman Bullish on More Deals
bloomberg.com
To view or add a comment, sign in
12,317 followers
CEO Rescue Dogs Rock DC -501(c)(3)-raising capital for dog rescues in the Washington DC area.🐾🐾🇺🇸 in the U.S.A.
3mo💪💪👍👍🙌